Chinese API suppliers' OEM agreement is focal point of Jiangsu camphor-cartel lawsuit

The legitimacy of contract-manufacturing agreements between two competing drug-ingredient suppliers is among the focal points in an administrative lawsuit challenging the Jiangsu antitrust regulator’s penalty decision over a camphor cartel. At the...

Already a subscriber? Click here to view full article